{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:34:08Z","timestamp":1785818048032,"version":"3.56.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1007\/s11940-003-0001-4","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T19:07:37Z","timestamp":1180984057000},"page":"93-110","source":"Crossref","is-referenced-by-count":23,"title":["Diagnosis and treatment of nonconvulsive status epilepticus in an intensive care unit setting"],"prefix":"10.1007","volume":"5","author":[{"given":"Stephan J.","family":"R\u00fceegg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Dichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"1_CR1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2165\/00023210-200115120-00003","volume":"15","author":"MC Walker","year":"2001","unstructured":"Walker MC: Diagnosis and treatment of non-convulsive status epilepticus. CNS Drugs 2001, 15:931\u2013939. This is the most recent review article that is focussed exclusively on NCSE. The epidemiology, diagnostic difficulties, and challenges of treatment are concisely outlined. The debate on the potential harmful effects of NCSE is diligently reflected.","journal-title":"CNS Drugs"},{"key":"1_CR2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2008-1040957","volume":"16","author":"PW Kaplan","year":"1996","unstructured":"Kaplan PW: Nonconvulsive status epilepticus. Semin Neurol 1996, 16:33\u201340.","journal-title":"Semin Neurol"},{"key":"1_CR3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00004691-199907000-00006","volume":"16","author":"PW Kaplan","year":"1999","unstructured":"Kaplan PW: Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J Clin Neurolphysiol 1999, 16:341\u2013352. This paper underscores the different challenges that are imposed on the clinician caring for patients with NCSE. Failure or delay to diagnose NCSE may put the patient at risk, as does inappropriate (over- or under-) treatment. It describes the lack of commonly accepted diagnostic criteria and classification, including introduction of distinct subgroups that leads to misconception of NCSE and impedes the implementation of very needed prospective studies.","journal-title":"J Clin Neurolphysiol"},{"key":"1_CR4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00004691-199907000-00003","volume":"16","author":"A Krumholz","year":"1999","unstructured":"Krumholz A: Epidemiology and evidence for morbidity of nonconvulsive status epilepticus. J Clin Neurophysiol 1999, 16:314\u2013322. This article focuses on the different types of NCSE, their epidemiology, and their distinct prognosis. Although the author agrees that AS does not have serious consequences, he outlines the probably harmful effects of complex-partial status epilepticus. Furthermore, the useful concept of epileptic encephalopathy, which may cause all forms of NCSE, including the subtle, subclinical, non-tonic-clonic, and electroencephalographic SE, is introduced. The latter share a particularly serious prognosis.","journal-title":"J Clin Neurophysiol"},{"key":"1_CR5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00004691-199512040-00005","volume":"12","author":"DM Treiman","year":"1995","unstructured":"Treiman DM: Electroclinical features of status epilepticus. J Clin Neurophysiol 1995, 12:343\u2013362.","journal-title":"J Clin Neurophysiol"},{"key":"1_CR6","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1212\/WNL.46.4.1029","volume":"46","author":"RJ DeLorenzo","year":"1996","unstructured":"DeLorenzo RJ, Hauser WA, Towne AR, et al.: A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virgina. Neurology 1996, 46:1029\u20131035.","journal-title":"Neurology"},{"key":"1_CR7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1212\/WNL.50.3.735","volume":"50","author":"D Hesdorffer","year":"1998","unstructured":"Hesdorffer D, Logroscino G, Cascino G, et al.: Incidence of status epilepticus in Rochester, Minnesota 1965\u20131984. Neurology 1998, 50:735\u2013741.","journal-title":"Neurology"},{"key":"1_CR8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1212\/WNL.55.5.693","volume":"55","author":"A Coeytaux","year":"2000","unstructured":"Coeytaux A, Jallon P, Galobardes B, Morabia A: Incidence of status epilepticus in French-speaking Switzerland (EPISTAR). Neurology 2000, 55:693\u2013697.","journal-title":"Neurology"},{"key":"1_CR9","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1046\/j.1528-1157.2001.01101.x","volume":"42","author":"S Knake","year":"2001","unstructured":"Knake S, Rosenow F, Vescovi M, et al.: Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 2001, 42:714\u2013718.","journal-title":"Epilepsia"},{"key":"1_CR10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00002512-200118020-00006","volume":"18","author":"EJ Waterhouse","year":"2001","unstructured":"Waterhouse EJ, DeLorenzo RJ: Status epilepticus in older patients: epidemiology and treatment options. Drugs Aging 2001, 18:133\u2013142.","journal-title":"Drugs Aging"},{"key":"1_CR11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/WNL.54.2.340","volume":"54","author":"AR Towne","year":"2000","unstructured":"Towne AR, Waterhouse EJ, Boggs JG, et al.: Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 2000, 54:340\u2013345. This retrospective study evaluated the EEGs of comatose patients without overt seizure activity. Eight percent of these patients met the criteria set for NCSE, indicating that NCSE is common in comatose patients in the ICU. Thus, EEG may be a helpful diagnostic tool in the evaluation of these patients, especially when clinical signs of seizures are absent.","journal-title":"Neurology"},{"key":"1_CR12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1528-1157.2002.13001.x","volume":"43","author":"PN Patsalos","year":"2002","unstructured":"Patsalos PN, Froscher W, Pisani F, van Rijn CM: The importance of drug interactions in epilepsy therapy. Epilepsia 2002, 43:365\u2013385. This very up-to-date article covers the broad range of implications of drug interactions during therapy of epilepsy. The authors provide rich pharmacodynamic and pharmacokinetic information, and helpful summary tables about the old and new AEDs and other commonly used drugs, and their influence on cytochrome P450 systems. Special emphasis is given to the impact on the therapeutic effect and to the outcome of these drug interactions.","journal-title":"Epilepsia"},{"key":"1_CR13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00004691-199907000-00005","volume":"16","author":"KG Jordan","year":"1999","unstructured":"Jordan KG: Nonconvulsive status epilepticus in acute brain injury. J Clin Neurophysiol 1999, 16:332\u2013340.","journal-title":"J Clin Neurophysiol"},{"key":"1_CR14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1528-1157.2001.01600.x","volume":"42","author":"S Shinnar","year":"2001","unstructured":"Shinnar S, Berg AT, Treiman DM, et al.: Status epilepticus and tiagabine therapy: review of safety data and epidemiologic comparisons. Epilepsia 2001, 42:372\u2013379.","journal-title":"Epilepsia"},{"issue":"suppl","key":"1_CR15","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1046\/j.1528-1157.43.s.3.9.x","volume":"43","author":"RP Brenner","year":"2002","unstructured":"Brenner RP: Is it status? Epilepsia 2002, 43(suppl):S103-S113. This very instructive and concise article outlines the challenges to diagnose NCSE in the different settings of ambulatory and hospitalized patients. Special emphasis is given to the various EEG patterns with excellent illustrations. The article also briefly summarizes the clinical features, incidence, and outcome of NCSE.","journal-title":"Epilepsia"},{"key":"1_CR16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1528-1157.1996.tb00628.x","volume":"37","author":"PW Kaplan","year":"1996","unstructured":"Kaplan PW: Nonconvulsive status epilepticus in the emergency room. Epilepsia 1996, 37:643\u2013650. This is the first study devoted to NCSE evaluated exclusively in the emergency room. Key observations include NCSE commonly misdiagnosed as a psychiatric disorder, a significant delay in diagnosis of near half of the patients, and a clinical continuum between partial and generalized NCSE. Because of the pleomorphic clinical presentation of NCSE, immediate EEG recording and the response to an AED trial may best guide to the diagnosis.","journal-title":"Epilepsia"},{"key":"1_CR17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00004691-199901000-00002","volume":"16","author":"KG Jordan","year":"1999","unstructured":"Jordan KG: Continuous EEG monitoring in the neuroscience intensive care unit and emergency department. J Clin Neurophysiol 1999, 16:14\u201339.","journal-title":"J Clin Neurophysiol"},{"key":"1_CR18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0920-1211(94)90008-6","volume":"18","author":"M Privitera","year":"1994","unstructured":"Privitera M, Hoffman M, Moore JL, Jester D: EEG detection of nontonic-clonic status epilepticus in patients with altered consciousness. Epilepsy Res 1994, 18:155\u2013166.","journal-title":"Epilepsy Res"},{"key":"1_CR19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00004691-200009000-00006","volume":"17","author":"GB Young","year":"2000","unstructured":"Young GB: The EEG in coma. J Clin Neurophysiol 2000, 17:473\u2013485.","journal-title":"J Clin Neurophysiol"},{"key":"1_CR20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00019052-200204000-00014","volume":"15","author":"M Reuber","year":"2002","unstructured":"Reuber M, House AO: Treating patients with psychogenic non-epileptic seizures. Curr Opin Neurol 2002, 15:207\u2013211.","journal-title":"Curr Opin Neurol"},{"key":"1_CR21","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1528-1157.1999.tb00855.x","volume":"40","author":"FW Drislane","year":"1999","unstructured":"Drislane FW, Blum AS, Schomer DL: Focal status epilepticus: clinical features and significance of different EEG patterns. Epilepsia 1999, 40:1254\u20131260.","journal-title":"Epilepsia"},{"key":"1_CR22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1528-1157.1994.tb02910.x","volume":"35","author":"MA Granner","year":"1994","unstructured":"Granner MA, Lee SJ: Nonconvulsive status epilepticus: EEG analysis in a large series. Epilepsia 1994, 35:42\u201347.","journal-title":"Epilepsia"},{"key":"1_CR23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00004691-199611000-00007","volume":"13","author":"B Pohlmann-Eden","year":"1996","unstructured":"Pohlmann-Eden B, Hoch DB, Cochius JI, Chiappa KH: Periodic lateralized epileptiform discharges: a critical review. J Clin Neurophysiol 1996, 13:519\u2013530.","journal-title":"J Clin Neurophysiol"},{"key":"1_CR24","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1212\/WNL.57.7.1175","volume":"57","author":"E Garzon","year":"2001","unstructured":"Garzon E, Fernandez RM, Sakamoto AC: Serial EEG during human status epilepticus: evidence for PLED as an ictal pattern. Neurology 2001, 57:1175\u20131183.","journal-title":"Neurology"},{"issue":"suppl","key":"1_CR25","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1046\/j.1528-1157.43.s.3.7.x","volume":"43","author":"ML Scheuer","year":"2002","unstructured":"Scheuer ML: Continuous EEG monitoring in the intensive care unit. Epilepsia 2002, 43(suppl):S114-S127. This article summarizes the current applications of continuous EEG in the ICU, for example, monitoring seizure activity in NCSE, during cerebral ischemia, after head injury, and for coma diagnosis and prognosis. Clinical examples are instructively illustrated, and the technique and usefulness of color or gray scale spectrographic transformations are well explained.","journal-title":"Epilepsia"},{"key":"1_CR26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.58.1.139","volume":"58","author":"J Claassen","year":"2002","unstructured":"Claassen J, Lokin JK, Fitzsimmons BFM, et al.: Predictors of functional disability and mortality after status epilepticus. Neurology 2002, 58:139\u2013142. This recent retrospective study identifies by multivariate analysis increased age (odds ratio [OR] 1.1; confidence interval [CI] 1.0 to 1.1) and acute symptomatic seizures (OR 6.0; CI 1.2 to 30.3) as predictors of mortality and increased length of hospitalization (OR 1.04; CI 1.0 to 1.1), and acute symptomatic seizures (OR 3.9; CI 1.0 to 14.7) as predictors of functional disability.","journal-title":"Neurology"},{"key":"1_CR27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1212\/WNL.58.4.537","volume":"58","author":"G Logroscino","year":"2002","unstructured":"Logroscino G, Hesdorffer DC, Cascino GD, et al.: Long-term mortality after a first episode of status epilepticus. Neurology 2002, 58:537\u2013541.","journal-title":"Neurology"},{"key":"1_CR28","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1528-1157.1998.tb01311.x","volume":"39","author":"B Litt","year":"1998","unstructured":"Litt B, Wityk RJ, Hertz SH, et al.: Nonconvulsive status epilepticus in the critical ill elderly. Epilepsia 1998, 39:1194\u20131202.","journal-title":"Epilepsia"},{"key":"1_CR29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/archneur.55.1.119","volume":"55","author":"M Aminoff","year":"1998","unstructured":"Aminoff M: Do nonconvulsive seeizures damage the brain? No: controversies in neurology. Arch Neurol 1998, 55:119\u2013121.","journal-title":"Arch Neurol"},{"key":"1_CR30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archneur.55.1.117","volume":"55","author":"GB Young","year":"1998","unstructured":"Young GB: Do nonconvulsive seizures damage the brain? Yes: controversies in neurology. Arch Neurol 1998, 55:117\u2013119.","journal-title":"Arch Neurol"},{"key":"1_CR31","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/brain\/awf203","volume":"125","author":"MC Walker","year":"2002","unstructured":"Walker MC, White HS, Sander JWAS: Disease modification in partial epilepsy. Brain 2002, 125:1937\u20131950. This latest article is a comprehensive, thorough review of the current knowledge about the impact and pathophysiologic processes of focal seizures of different origin (eg, SE, hyperthermic (febrile) seizures, seizures after hypoxia, or traumatic brain injury) on the later development of an epileptic disorder. The data of the available animal and human studies are presented, and potential antiepileptogenic strategies are outlined.","journal-title":"Brain"},{"key":"1_CR32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00019052-200104000-00012","volume":"14","author":"DM Treiman","year":"2001","unstructured":"Treiman DM: Therapy of status epilepticus in adults and children. Curr Opin Neurol 2001, 14:203\u2013210.","journal-title":"Curr Opin Neurol"},{"key":"1_CR33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00004691-199907000-00004","volume":"16","author":"FW Drislane","year":"1999","unstructured":"Drislane FW: Evidence against permanent neurologic damage from nonconvulsive status epilepticus. J Clin Neurophysiol 1999, 16:323\u2013331.","journal-title":"J Clin Neurophysiol"},{"key":"1_CR34","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM199804023381407","volume":"338","author":"DH Lowenstein","year":"1998","unstructured":"Lowenstein DH, Alldredge BK: Status epilepticus. N Engl J Med 1998, 338:970\u2013976.","journal-title":"N Engl J Med"},{"issue":"suppl","key":"1_CR35","first-page":"II22","volume":"70","author":"S Shorvon","year":"2001","unstructured":"Shorvon S: The management of status epilepticus. J Neurol Neurosurg Psychiatry 2001, 70(suppl):II22-II27. This very concise overview is a helpful source of direct advice how to manage SE (eg, treatment algorithm, all medications given with their dosages). Furthermore, the article covers the pathophysiologic changes during SE, outlines the medical complications of SE, and lists probable causes of treatment failures.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1_CR36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0733-8619(05)70022-0","volume":"19","author":"BJ Smith","year":"2001","unstructured":"Smith BJ: Treatment of status epilepticus. Neurol Clin 2001, 19:347\u2013369.","journal-title":"Neurol Clin"},{"key":"1_CR37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11910-002-0010-9","volume":"2","author":"LJ Hirsch","year":"2002","unstructured":"Hirsch LJ, Claassen J: The current state of treatment of status epilepticus. Curr Neurol Neurosci Rep 2002, 2:345\u2013356.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1_CR38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11940-002-0031-3","volume":"4","author":"EJ Waterhouse","year":"2002","unstructured":"Waterhouse EJ: Status epilepticus. Curr Treat Options Neurol 2002, 4:309\u2013317.","journal-title":"Curr Treat Options Neurol"},{"key":"1_CR39","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","volume":"339","author":"DM Treiman","year":"1998","unstructured":"Treiman DM, Myers PD, Walton NY, et al.: A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998, 339:792\u2013798.","journal-title":"N Engl J Med"},{"key":"1_CR40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2165\/00003088-199936060-00003","volume":"36","author":"E Rey","year":"1999","unstructured":"Rey E, Treluyer JM, Pons G: Pharmacokinetic optimization of benzodiazepine therapy for acute seizures: focus on delivery routes. Clin Pharmacokinet 1999, 36:409\u2013424.","journal-title":"Clin Pharmacokinet"},{"issue":"suppl","key":"1_CR41","first-page":"A42","volume":"2","author":"S Karceski","year":"2001","unstructured":"Karceski S, Morell M, Carpenter D: Treatment of epilepsy: status epilepticus. The Expert Consensus Guideline Series. Epilepsy Behav 2001, 2(suppl):A42-A47.","journal-title":"Epilepsy Behav"},{"key":"1_CR42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1212\/WNL.42.1.104","volume":"42","author":"P Thomas","year":"1992","unstructured":"Thomas P, Beaumanoir A, Genton P, et al.: De novo absence status of late onset: report of 11 cases. Neurology 1992, 42:104\u2013110.","journal-title":"Neurology"},{"key":"1_CR43","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1212\/WNL.52.6.1174","volume":"52","author":"P Thomas","year":"1999","unstructured":"Thomas P, Zifkin B, Migneco O, et al.: Nonconvulsive status epilepticus of frontal origin. Neurology 1999, 52:1174\u20131183.","journal-title":"Neurology"},{"issue":"suppl","key":"1_CR44","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1017\/S0317167100034648","volume":"25","author":"MJ Aminoff","year":"1998","unstructured":"Aminoff MJ: Management of status epilepticus. Can J Neurol Sci 1998, 25(suppl):S4-S6.","journal-title":"Can J Neurol Sci"},{"issue":"suppl","key":"1_CR45","first-page":"123","volume":"24","author":"NY Walton","year":"1996","unstructured":"Walton NY, Treiman DM: Rational polytherapy in the treatment of status epilepticus. Epilepsy Res 1996, 24(suppl):123\u2013139.","journal-title":"Epilepsy Res"},{"key":"1_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002826-199702000-00001","volume":"20","author":"TR Browne","year":"1997","unstructured":"Browne TR: Fosphenytoin (Cerebyx). Clin Neuropharmacol 1997, 20:1\u201312.","journal-title":"Clin Neuropharmacol"},{"key":"1_CR47","first-page":"245","volume":"42","author":"FM Pryor","year":"2001","unstructured":"Pryor FM, Gidal B, Ramsay RE, et al.: Fosphenytoin: pharmacokinetics and tolerance of intramuscular loading doses. Epilepsia 2001, 42:245\u2013250.","journal-title":"Epilepsia"},{"key":"1_CR48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2165\/00002018-200022060-00004","volume":"22","author":"JC DeToledo","year":"2000","unstructured":"DeToledo JC, Ramsay RE: Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costs. Drug Saf 2000, 22:459\u2013466.","journal-title":"Drug Saf"},{"key":"1_CR49","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1592\/phco.20.11.908.35269","volume":"20","author":"DR Touchette","year":"2000","unstructured":"Touchette DR, Rhoney DH: Cost-minimization analysis of phenytoin and fosphenytoin in the emergency department. Pharmacotherapy 2000, 20:908\u2013916.","journal-title":"Pharmacotherapy"},{"key":"1_CR50","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1378\/chest.105.2.602","volume":"105","author":"J Lindow","year":"1994","unstructured":"Lindow J, Wijdicks EF: Phenytoin toxicity associated with hypoalbuminemia in crtically ill patients. Chest 1994, 105:602\u2013604.","journal-title":"Chest"},{"key":"1_CR51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/seiz.2000.0507","volume":"10","author":"D Kitchen","year":"2001","unstructured":"Kitchen D, Smith D: Problems with phenytoin administration in neurology\/neurosurgery ITU patients receiving enteral feeding. Seizure 2001, 10:265\u2013268.","journal-title":"Seizure"},{"key":"1_CR52","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1528-1157.2001.29300.x","volume":"42","author":"JC DeToledo","year":"2001","unstructured":"DeToledo JC, Lowe MR, Rabinstein A, Villaviza N: Cardiac arrest after fast intravenous infusion of phenytoin mistaken for fosphenytoin. Epilepsia 2001, 42:288.","journal-title":"Epilepsia"},{"key":"1_CR53","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/ana.410380418","volume":"38","author":"O Devinsky","year":"1995","unstructured":"Devinsky O, Leppik I, Willmore LJ, et al.: Safety of intravenous valproate. Ann Neurol 1995, 38:670\u2013674.","journal-title":"Ann Neurol"},{"key":"1_CR54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0920-1211(99)00005-4","volume":"35","author":"V Venkataraman","year":"1999","unstructured":"Venkataraman V, Wheless JW: Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients. Epilepsy Res 1999, 35:147\u2013153.","journal-title":"Epilepsy Res"},{"key":"1_CR55","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1212\/WNL.55.5.722","volume":"55","author":"S Sinha","year":"2000","unstructured":"Sinha S, Naritoku DK: Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology 2000, 55:722\u2013724.","journal-title":"Neurology"},{"key":"1_CR56","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1345\/aph.10387","volume":"35","author":"BM Hodges","year":"2001","unstructured":"Hodges BM, Mazur JE: Intravenous valproate in status epilepticus. Ann Pharmacother 2001, 35:1465\u20131470.","journal-title":"Ann Pharmacother"},{"key":"1_CR57","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1592\/phco.21.20.1549.34480","volume":"21","author":"SA Chapman","year":"2001","unstructured":"Chapman SA, Wacksman GP, Patterson BD: Pancreatitis associated with valproic acid: a review of the literature. Pharmacotherapy 2001, 21:1549\u20131560.","journal-title":"Pharmacotherapy"},{"key":"1_CR58","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/archneur.59.2.188","volume":"59","author":"TP Bleck","year":"2002","unstructured":"Bleck TP: Refractory status epilepticus [editorial]. Arch Neurol 2002, 59:188\u2013189.","journal-title":"Arch Neurol"},{"key":"1_CR59","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archneur.59.2.205","volume":"59","author":"SA Mayer","year":"2002","unstructured":"Mayer SA, Claassen J, Lokin J, et al.: Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002, 59:205\u2013210. In this retrospective cohort study, the authors report that RSE (defined as seizures lasting longer than 60 minutes despite treatment with a benzodiazepine and a second intravenous anticonvulsant) occurred in approximately 30% of patients with SE. They identified NCSE and focal motor seizures at onset as risk factors for RSE. In addition, RSE is associated with increased length of hospital stay and disability.","journal-title":"Arch Neurol"},{"key":"1_CR60","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1528-1157.1999.tb00775.x","volume":"40","author":"KB Krishnamurthy","year":"1999","unstructured":"Krishnamurthy KB, Drislane FW: Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia 1999, 40:759\u2013762.","journal-title":"Epilepsia"},{"key":"1_CR61","first-page":"261","volume":"22","author":"NB Fountain","year":"1999","unstructured":"Fountain NB, Adams RE: Midazolam treatment of acute and refractory status epilepticus. Clin Neuropharmacol 1999, 22:261\u2013267.","journal-title":"Clin Neuropharmacol"},{"key":"1_CR62","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1212\/WNL.57.6.1036","volume":"57","author":"J Claassen","year":"2001","unstructured":"Claassen J, Hirsch LJ, Emerson RG, et al.: Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology 2001, 57:1036\u20131042.","journal-title":"Neurology"},{"key":"1_CR63","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003088-200038010-00003","volume":"38","author":"GK Dresser","year":"2000","unstructured":"Dresser GK, Spence JD, Bailey DG: Pharmacokineticpharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin Pharmacokinet 2000, 38:41\u201357.","journal-title":"Clin Pharmacokinet"},{"key":"1_CR64","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1046\/j.1528-1157.2001.27500.x","volume":"42","author":"A Prasad","year":"2001","unstructured":"Prasad A, Worall BB, Bertram EH, Bleck TP: Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia 2001, 42:380\u2013386.","journal-title":"Epilepsia"},{"key":"1_CR65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1528-1157.2000.tb01513.x","volume":"41","author":"M Begemann","year":"2000","unstructured":"Begemann M, Rowan AJ, Tuhrim S: Treatment of refractory complex-partial status epilepticus with propofol: case report. Epilepsia 2000, 41:105\u2013109.","journal-title":"Epilepsia"},{"key":"1_CR66","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1212\/WNL.58.9.1327","volume":"58","author":"B Walder","year":"2002","unstructured":"Walder B, Tramer MR, Seeck M: Seizure-like phenomena and propofol: a systematic review. Neurology 2002, 58:1327\u20131332.","journal-title":"Neurology"},{"key":"1_CR67","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1528-1157.2002.28501.x","volume":"43","author":"J Claassen","year":"2002","unstructured":"Claassen J, Hirsch LJ, Emerson RG, Mayer SA: Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002, 43:146\u2013153. Each of these three drugs has been shown effective in treatment of RSE with no significant advantages of any of them. However, the impact of the study is limited in that it was done retrospectively, and the intensity of treatment substantially varied between phenobarbital and propofol or midazolam. Additionally, mortality in patients with NCSE seemed not to be lowered by any drug.","journal-title":"Epilepsia"},{"key":"1_CR68","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1345\/aph.1A032","volume":"36","author":"TE Welty","year":"2002","unstructured":"Welty TE, Gidal BE, Ficker DM, Privitera MD: Levetiracetam: a different approach to the pharmacotherapy of epilepsy. Ann Pharmacother 2002, 36:296\u2013304.","journal-title":"Ann Pharmacother"},{"key":"1_CR69","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1212\/WNL.51.6.1765","volume":"51","author":"RD Sheth","year":"1998","unstructured":"Sheth RD, Gidal BE: Refractory status epilepticus: response to ketamine. Neurology 1998, 51:1765\u20131766.","journal-title":"Neurology"},{"key":"1_CR70","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1553-2712.1997.tb03820.x","volume":"4","author":"IA Walker","year":"1997","unstructured":"Walker IA, Slovis CM: Lidocaine in the treatment of status epilepticus. Acad Emerg Med 1997, 4:918\u2013922.","journal-title":"Acad Emerg Med"},{"key":"1_CR71","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2044.2002.2412_30.x","volume":"57","author":"M Thulasimani","year":"2002","unstructured":"Thulasimani M, Ramaswamy S: The role of paraldehyde and lidocaine in the management of status epilepticus. Anaesthesia 2002, 57:99\u2013100.","journal-title":"Anaesthesia"},{"key":"1_CR72","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00000542-198911000-00005","volume":"71","author":"WA Kofke","year":"1989","unstructured":"Kofke WA, Young RS, Davis P, et al.: Isoflurane for refractory status epilepticus: a clinical series. Anesthesiology 1989, 71:653\u2013659.","journal-title":"Anesthesiology"},{"key":"1_CR73","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00124509-200106000-00010","volume":"17","author":"V Parker","year":"2001","unstructured":"Parker V, Nobler MS, Pedley TA, Sackheim HA: A unilateral, prolonged, nonconvulsive seizure in a patient treated with bilateral ECT. J ECT 2001, 17:141\u2013145.","journal-title":"J ECT"},{"key":"1_CR74","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00124509-200109000-00013","volume":"17","author":"SH Lisanby","year":"2001","unstructured":"Lisanby SH, Bazil CW, Resor SR, et al.: ECT in the treatment of status epilepticus. J ECT 2001, 17:210\u2013215.","journal-title":"J ECT"},{"key":"1_CR75","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1528-1157.1990.tb05361.x","volume":"31","author":"PC Ness Van","year":"1990","unstructured":"Van Ness PC: Pentobarbital and EEG burst suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin. Epilepsia 1990, 31:61\u201367.","journal-title":"Epilepsia"},{"key":"1_CR76","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1528-1157.1992.tb01707.x","volume":"33","author":"DG Gorman","year":"1992","unstructured":"Gorman DG, Shields D, Shewmon DA, et al.: Neurosurgical treatment of refractory status epilepticus. Epilepsia 1992, 33:546\u2013549.","journal-title":"Epilepsia"},{"key":"1_CR77","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0920-1211(01)00252-2","volume":"46","author":"X Ma","year":"2001","unstructured":"Ma X, Liporace J, O\u2019Connor MJ, Sperling MR: Neurosurgical treatment of medically intractable status epilepticus. Epilepsy Res 2001, 46:33\u201338.","journal-title":"Epilepsy Res"},{"key":"1_CR78","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/seiz.2001.0521","volume":"10","author":"CH D\u2019Giano","year":"2001","unstructured":"D\u2019Giano CH, Del C, Garcia M, et al.: Treatment of refractory partial status epilepticus with multiple subpial transsection: case report. Seizure 2001, 10:382\u2013385.","journal-title":"Seizure"},{"key":"1_CR79","first-page":"173","volume":"76","author":"DM Treiman","year":"1998","unstructured":"Treiman DM: Clinical trials for status epilepticus. Adv Neurol 1998, 76:173\u2013178.","journal-title":"Adv Neurol"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-003-0001-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-003-0001-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-003-0001-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T15:35:56Z","timestamp":1628955356000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-003-0001-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["1"],"URL":"https:\/\/doi.org\/10.1007\/s11940-003-0001-4","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}